All language subtitles for 28-en

af Afrikaans
ak Akan
sq Albanian
am Amharic
hy Armenian
az Azerbaijani
eu Basque
be Belarusian
bem Bemba
bn Bengali
bh Bihari
bs Bosnian
br Breton
bg Bulgarian
km Cambodian
ca Catalan
ceb Cebuano
chr Cherokee
ny Chichewa
zh-CN Chinese (Simplified)
zh-TW Chinese (Traditional)
co Corsican
hr Croatian
cs Czech
da Danish
nl Dutch
en English
eo Esperanto
et Estonian
ee Ewe
fo Faroese
tl Filipino
fi Finnish
fr French
fy Frisian
gaa Ga
gl Galician
ka Georgian
de German
el Greek
gn Guarani
gu Gujarati
ht Haitian Creole
ha Hausa
haw Hawaiian
iw Hebrew
hi Hindi
hmn Hmong
hu Hungarian
is Icelandic
ig Igbo
id Indonesian
ia Interlingua
ga Irish
it Italian
ja Japanese
jw Javanese
kn Kannada
kk Kazakh
rw Kinyarwanda
rn Kirundi
kg Kongo
ko Korean
kri Krio (Sierra Leone)
ku Kurdish
ckb Kurdish (Soranรฎ)
ky Kyrgyz
lo Laothian
la Latin
lv Latvian
ln Lingala
lt Lithuanian
loz Lozi
lg Luganda
ach Luo
lb Luxembourgish
mk Macedonian
mg Malagasy
ms Malay
ml Malayalam
mt Maltese
mi Maori
mr Marathi
mfe Mauritian Creole
mo Moldavian
mn Mongolian
my Myanmar (Burmese)
sr-ME Montenegrin
ne Nepali
pcm Nigerian Pidgin
nso Northern Sotho
no Norwegian
nn Norwegian (Nynorsk)
oc Occitan
or Oriya
om Oromo
ps Pashto
fa Persian
pl Polish
pt-BR Portuguese (Brazil)
pt Portuguese (Portugal)
pa Punjabi
qu Quechua
ro Romanian
rm Romansh
nyn Runyakitara
ru Russian
sm Samoan
gd Scots Gaelic
sr Serbian
sh Serbo-Croatian
st Sesotho
tn Setswana
crs Seychellois Creole
sn Shona
sd Sindhi
si Sinhalese
sk Slovak
sl Slovenian
so Somali
es Spanish
es-419 Spanish (Latin American)
su Sundanese
sw Swahili
sv Swedish
tg Tajik
ta Tamil
tt Tatar
te Telugu
th Thai
ti Tigrinya
to Tonga
lua Tshiluba
tum Tumbuka
tr Turkish
tk Turkmen
tw Twi
ug Uighur
uk Ukrainian
ur Urdu
uz Uzbek
vi Vietnamese
cy Welsh
wo Wolof
xh Xhosa
yi Yiddish
yo Yoruba
zu Zulu

Original subtitles

ERIC S. LANDER: It all works beautifully.

You're getting sugar, you're producing ATP.

What if you don't need so much ATP?

What if you don't have so much sugar?

Should we just have this pathway be running that way all the time or would

you like it to be, if you're getting fancy, have dials on it, to be a

little adjustable?

STUDENT: Something tells me that.

ERIC S. LANDER: Something tells you we're going to want

some dials on that.

So let's take a look at how we can regulate this nice pathway.

A goes to B goes to C and maybe C could get used to make D, E, F, or

maybe it could get used to make G, H, I. We're not going to fuss over any

molecular structures here.

Suppose we have too much F. The cell says, I've got too much F. I'm trying

to balance things out.

I've got too much F. Maybe F is ATP, maybe F is something else--

I've got too much of it--

yet this pathway's just churning out more of it.

That's not good-- it's a waste.

I don't want that much more F. What do you want to do?

STUDENT: Turn it down.

ERIC S. LANDER: I'd like to turn down the dial.

What dial would I like to turn down?

How about this one?

If I turn down the dial here, I won't make so much F.

STUDENT: [INAUDIBLE].

ERIC S. LANDER: I'll make a lot of E, though.

That's not so good.

No.

I could turn down this, but then I'll make a lot of D. Maybe what I should

do is turned down this one.

So you would like to have some way to have excess F and turn

down the dial there.

By the way, what's the dial that we're talking about?

What is that arrow?

That arrow refers to--?

STUDENT: Rate.

ERIC S. LANDER: Sorry?

STUDENT: Rate.

ERIC S. LANDER: The rate.

And what controls that rate?

STUDENT: Enzymes?

ERIC S. LANDER: Enzymes are good at controlling rates.

We can really slow things down if we could just persuade that enzyme to

please stop working or work a little less well.

So imagine if we had this enzyme.

Here's our enzyme, and it's got a site here for C, and C, it's going to

convert it into D. I'd like to have that enzyme please slow down if

there's too much F. How's it going to know there's too much F and what would

it do in response to it?

STUDENT: Would F block the active site?

ERIC S. LANDER: F might block the active site.

That's a possibility.

But probably F is a different shaped molecule.

It doesn't fit in that active site so well.

Yeah?

STUDENT: Have a site for F that causes it to change shape so [INAUDIBLE]

fit in.

ERIC S. LANDER: So maybe there's some F binding place on the molecule.

And when it binds F, it shifts its shape.

Can proteins shift their shapes?

STUDENT: Yes.

ERIC S. LANDER: We saw proteins do a lot of shape shifting.

So maybe there's an F site, and it changes its shape into another shape.

The word for "other" in Greek is "allo." The word for "shape," three

dimensional shape, is "stereo." This is called allosteric regulation.

Other shape-- it just means other shape regulation.

So F binds to that protein.

And we were wondering, actually, weren't we, about this big protein

with all these amino acids and all these things and what'd you

need all that for?

Well, some of that might be there because F can bind to it and then

transmit the binding of F into its shape shifting and

affect the active site.

That's a pretty good trick.

Suppose I have too much I.

STUDENT: Same thing.

ERIC S. LANDER: Same deal.

I go back there.

Suppose I have too much F and I. Where would I like to slow this thing down?

Too much F and too much I.

STUDENT: [INAUDIBLE].

ERIC S. LANDER: I might want to slow it down over here.

So maybe that enzyme--

who knows?-- could have binding sites for F and I, a possibility.

Now suppose it's not that I have too much product at the end of the

reaction, but I have too much reactant at the beginning of the reaction.

I've got too much glucose and I haven't made enough ATP.

It's building up--

I've got a lot of A. I want to get this reaction to go faster.

I can't change the delta Gs, but I want this reaction to go faster.

How am I going to get it to go faster?

STUDENT: [INAUDIBLE]

so you get to slow it down?

ERIC S. LANDER: Well, these were things I slowed it down that way.

But suppose I want to goose up.

Yep?

STUDENT: [INAUDIBLE]

make that more favorable to it?

ERIC S. LANDER: Ah, why can't I run allosteric regulation in the

activation direction also?

Maybe when As bind to a downstream enzyme, it activates the enzyme and

makes it better.

So I can run that both ways.

STUDENT: Is that what you said happened in the hemoglobin, sort of?

ERIC S. LANDER: Well, in the hemoglobin, that's a

little bit like it.

It's not quite the same thing, but when one oxygen bound in hemoglobin,

it made it more favorable for another one for the-- so in fact, hemoglobin

changed its shape to make more binding possible.

Hemoglobin is not an enzyme, but it's exactly the same principle.

It's allosterically changing to improve binding, and what you're

saying is we could allosterically change to improve our

enzyme speed as well.

So we can have either--

we could call the first thing we talked about feedback inhibition, or

we could have feedforward activation.

And that happens--

it happens all over the place.

Probably when this reaction first evolved in evolution there, long, long

time ago, it didn't have all those nice tweaks.

But over time, as organisms competed with each other, those who evolved

cute tricks like being able to do feedback inhibition or feedforward

activation outcompeted their friends and all of these cool little tricks

were layered on top and on top and on top.

So we actually see this happening in glycolosis.

Glucose to glucose-6-phosphate.

First step, glucose to glucose-6-phosphate.

That's an expensive step, isn't it?

I'm spending an ATP.

Well, suppose I have a lot of glucose-6-phosphate around.

Would I want to do that?

It turns out glucose-6-phosphate itself can inhibit the enzyme that

makes glucose-6-phosphate.

Pretty cool.

That enzyme's called hexokinase, because kinase means puts a

phosphate group on.

And so the product actually inhibits the enzyme and says, if I've got too

much product, please don't bother making any more.

Now there are some other things here.

Some of these other things here can be inhibited by too much ATP.

Don't got enough ATP?

I can inhibit them, because there's an ATP binding site.

If I've got too little ATP, then there's too much ADP, or actually,

often the molecule that has just one phosphate, adenosine monophosphate,

and those guys can come back and they can activate.

And in fact, this is an incredibly important and an expensive pathway.

I'm spending ATPs and it's highly regulated along the way.

So that's what happens there.

There's actually a lot of a lot of fancy tricks that I won't get into,

and not all the regulation for most pathways is even fully understood

because they're still probably lots of aspects we don't fully know.

All right.

Take a moment and test yourself with a pretty hard question about the

regulation of pathways.

Can't find what you're looking for?
Get subtitles in any language from opensubtitles.com, and translate them here.